Meet the Blood Cancer Taskforce: Dr Rishi Kotecha
Meet Dr Rishi, a Consultant Paediatric Oncologist & Clinical Haematologist.
- Advocacy and policy
Meet Dr Rishi, a Consultant Paediatric Oncologist & Clinical Haematologist.
Acalabrutinib (Calquence®) will be added to the therapy arsenal for CLL and SLL.
The Pharmaceutical Benefits Advisory Committee (PBAC) considered four blood cancer treatments at its March 2020 meeting including a drug for myeloma – plitidepsin (Aplidin®).
The Leukaemia Foundation welcomes the commitment from the Federal Health Minister Greg Hunt to establish a Blood Cancer Taskforce and Action Plan.